Profound Medical Corp
TSX:PRN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Profound Medical Corp
TSX:PRN
|
CA |
|
SFC Energy AG
XETRA:F3C
|
DE |
|
JACCS Co Ltd
TSE:8584
|
JP |
|
Loblaw Companies Ltd
TSX:L
|
CA |
|
Lindab International AB
LSE:0MWK
|
SE |
|
M
|
Maxicity Holdings Ltd
HKEX:2295
|
HK |
|
H
|
HUHUTECH International Group Inc
NASDAQ:HUHU
|
CN |
|
SUNA Co Ltd
SZSE:002417
|
CN |
|
T
|
Telefonica Deutschland Holding AG
XETRA:O2D
|
DE |
|
Svenska Handelsbanken AB
STO:SHB A
|
SE |
|
K
|
Kamux Oyj
OMXH:KAMUX
|
FI |
|
Grand Vision Media Holdings PLC
LSE:GVMH
|
UK |
|
Huisen Household International Group Ltd
HKEX:2127
|
CN |
|
G
|
Grounds Real Estate Development AG
XETRA:AMMN
|
DE |
|
C
|
China Smarter Energy Group Holdings Ltd
HKEX:1004
|
HK |
|
G
|
G.S. Auto International Ltd
BSE:513059
|
IN |
|
Eastone Century Technology Co Ltd
SZSE:300310
|
CN |
|
Z
|
ZTE Corp
OTC:ZTCOF
|
CN |
|
G
|
Great Wall Terroir Holdings Ltd
HKEX:524
|
HK |
|
V
|
Vivenda Group SpA
F:XS0
|
IT |
|
P
|
Park Elektrik Uretim Madencilik Sanayi ve Ticaret AS
IST:PRKME.E
|
TR |
|
T
|
Thessaloniki Water Supply and Sewarage Company SA
XBER:T9W
|
GR |
|
C
|
China Daye Non-Ferrous Metals Mining Ltd
HKEX:661
|
HK |
|
U
|
Unusual Machines Inc
AMEX:UMAC
|
US |
Profound Medical Corp
Profound Medical Corp. develops, manufactures and markets therapeutic platforms that combine real-time magnetic resonance imaging with directional and focused ultrasound technology for incision-free ablation of diseased tissue. The company is headquartered in Mississauga, Ontario and currently employs 146 full-time employees. The company went IPO on 2014-09-24. The firm is commercializing TULSA-PRO, which is a technology that combines real-time magnetic resonance imaging (MRI), transurethral ultrasound and closed-loop temperature feedback control. TULSA-PRO is designed to provide customizable and predictable radiation-free ablation of a surgeon-defined prostate volume while protecting the urethra and rectum to help preserve the patient’s natural functional abilities. The firm is also commercializing Sonalleve, which is a therapeutic platform for the treatment of uterine fibroids and palliative pain treatment of bone metastases.
Profound Medical Corp. develops, manufactures and markets therapeutic platforms that combine real-time magnetic resonance imaging with directional and focused ultrasound technology for incision-free ablation of diseased tissue. The company is headquartered in Mississauga, Ontario and currently employs 146 full-time employees. The company went IPO on 2014-09-24. The firm is commercializing TULSA-PRO, which is a technology that combines real-time magnetic resonance imaging (MRI), transurethral ultrasound and closed-loop temperature feedback control. TULSA-PRO is designed to provide customizable and predictable radiation-free ablation of a surgeon-defined prostate volume while protecting the urethra and rectum to help preserve the patient’s natural functional abilities. The firm is also commercializing Sonalleve, which is a therapeutic platform for the treatment of uterine fibroids and palliative pain treatment of bone metastases.
This earnings call has not been analyzed yet.
If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.
